Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis

OBJECTIVE: We aimed to assess whether the introduction of the first infliximab biosimilar was associated with changes in overall infliximab consumption (originator and biosimilars) and price changes to the originator infliximab. METHODS: An interrupted time series analysis using infliximab sales dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Kuan, Blais, Joseph E., Pratt, Nicole L., Guo, Jeff Jianfei, Hillen, Jodie B., Stanford, Tyman, Ward, Michael, Lai, Edward Chia-Cheng, Shin, Ju-Young, Tong, Xinning, Fan, Min, Cheng, Franco W. T., Wu, Jing, Yeung, Winnie W. Y., Lau, Chak-Sing, Leung, Wai Keung, Wong, Ian C. K., Li, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195719/
https://www.ncbi.nlm.nih.gov/pubmed/36952213
http://dx.doi.org/10.1007/s40259-023-00589-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195719/
https://www.ncbi.nlm.nih.gov/pubmed/36952213
http://dx.doi.org/10.1007/s40259-023-00589-3

Ejemplares similares